Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1521

Sort by

Sort Order Select

Journal Articles

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

Blood (2020) 135 (19): 1696–1703.

https://doi.org/10.1182/blood.2019003347

Published: 2020

Includes: Supplemental data

Journal Articles

Description of a knock-in mouse model of JAK2 V617F MPN emerging from a minority of mutated hematopoietic stem cells

Olivier Mansier, Badr Kilani, Amélie V. Guitart, Alexandre Guy, Virginie Gourdou-Latyszenok, Caroline Marty, Marie Parrens, Isabelle Plo, William Vainchenker, Chloé James

Blood (2019) 134 (26): 2383–2387.

https://doi.org/10.1182/blood.2019001163

Published: 2019

Includes: Supplemental data

Journal Articles

JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera

Blood (2019) 134 (26): 2388–2398.

https://doi.org/10.1182/blood.2019001385

Published: 2019

Includes: Supplemental data

Journal Articles

Aberrant Responsiveness of Erythropoiesis to Iron Deficiency in Polycythemia Vera

Maria Feola, PhD, Daniel Moskop, Nada Terra, Young C. Park, Andrew Dunbar, MD, Ross L. Levine, MD, Ronald Hoffman, MD, Yelena Ginzburg, MD

Blood (2019) 134 (Supplement_1): 429.

https://doi.org/10.1182/blood-2019-131095

Published: 2019

Journal Articles

Thromboembolic Risk Reduction and High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: Results from a Randomized Controlled Study

Jean-Jacques Kiladjian, MD PhD, Christoph Klade, PhD, Pencho Georgiev, MD, Dorota Krochmalczyk, MD, Liana Gercheva-Kyuchukova, MD, Miklos Egyed, Viktor Rossiev, MD, Petr Dulicek, MD, Árpád Illés, MD D.Sc, Halyna Pylypenko, MD, Lylia Sivcheva, MD, Jiri Mayer, MD, Vera Yablokova, MD, Kurt Krejcy, MD, Hans Hasselbalch, MD, Robert Kralovics, PhD, Heinz Gisslinger, MD

Blood (2019) 134 (Supplement_1): 553.

https://doi.org/10.1182/blood-2019-122233

Published: 2019

Journal Articles

Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)

Jeffrey I. Zwicker, MD, David S. Lessen, MD, Philomena Colucci, DO, MS, Dilan Paranagama, PhD, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 168.

https://doi.org/10.1182/blood-2019-123835

Published: 2019

Journal Articles

Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms Receiving Cytoreductive Therapy with Hydroxyurea

Rong Wang, PhD, Rory M Shallis, MD, Scott F. Huntington, MD MPH, Amer M. Zeidan, MBBS, MHS, Steven D. Gore, MD, Amy J Davidoff, PhD MS, Xiaomei Ma, PhD, Nikolai A. Podoltsev, MD PhD

Blood (2019) 134 (Supplement_1): 330.

https://doi.org/10.1182/blood-2019-127568

Published: 2019

Journal Articles

Population Pharmacokinetics of Ruxolitinib in Patients with aGVHD Who Had an Inadequate Response to Corticosteroids

Xuejun Chen, Xiang Liu, Phillip Wang, Swamy Yeleswaram, PhD

Blood (2019) 134 (Supplement_1): 4534.

https://doi.org/10.1182/blood-2019-124027

Published: 2019

Journal Articles

Venetoclax and Cytarabine in AML Transformed from Myelofibrosis

John McKay, DO, Matthew Gayhart, MD, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Edward B. Perkins, MD PhD

Blood (2019) 134 (Supplement_1): 5140.

https://doi.org/10.1182/blood-2019-129429

Published: 2019

Journal Articles

Beyond the Routine CBC: Research CBC Parameters Associated with Myelodysplastic Syndromes and Underlying Mutations

Olga Pozdnyakova, MD PhD, Radu Stefan Niculescu, PhD, Tracey Kroll, BSc, Lisa Golemme, MLS (ASCP), MS, Nolan Raymond, MLS (ASCP), Debra Briggs, MT(ASCP), MS, Annette S. Kim, MD PhD

Blood (2019) 134 (Supplement_1): 5419.

https://doi.org/10.1182/blood-2019-125654

Published: 2019

Journal Articles

Seven Cases of JAK2 Mutation Negative Chronic Polycythemia Patients with Elevated IGF-1R

Guanfang Shi, PhD, Rewais Morcus, MD, Maksim Liaukovich, MD, Ching Wong, MD, Vladimir Gotlieb, Jen-Chin Wang, MD

Blood (2019) 134 (Supplement_1): 5389.

https://doi.org/10.1182/blood-2019-123006

Published: 2019

Journal Articles

Echocardiographic Probability of Pulmonary Hypertension in Myeloproliferative Neoplasms Patients in Chiang-Mai University

Yanika Jindamai, MD, Ekarat Rattarittamrong, MD, Arintaya Phrommintikul, MD, Lalita Yongsmith, MD, Thanawat Rattanathammethee, MD, Chatree Chai-Adisaksopha, MD PhD, Adisak Tantiworawit, MD, Lalita Norasetthada, MD

Blood (2019) 134 (Supplement_1): 5390.

https://doi.org/10.1182/blood-2019-126599

Published: 2019

Journal Articles

Increased Thromboxane in Patients with Polycythemia Vera and Thrombosis: Evidence for Aspirin-Unsuppressible Platelet Activation In Vivo

Rossella Rosari Cacciola, Elio Gentilini Cacciola, Veronica Vecchio, MDcal Student, Emma Cacciola, MD

Blood (2019) 134 (Supplement_1): 5372.

https://doi.org/10.1182/blood-2019-122828

Published: 2019

Journal Articles

The Frequency of Calr and MPL Gene Mutations in Jak2 V617F - Positive Chronic Myeloproliferative Neoplasms in Russia

Tatiana V Makarik, PhD, Adhamjon O Abdullaev, MD PhD, Sergei M. Kulikov, PhD, Elena E Nikulina, Svetlana A Treglazova, Irina N Subortseva, MD, Alla M. Kovrigina, MD PhD, Anait L. Melikyan, MD PhD, Andrey B Sudarikov, PhD DSc, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5400.

https://doi.org/10.1182/blood-2019-124767

Published: 2019

Journal Articles

REVEAL: Characteristics of Patients with Polycythemia Vera Who Were Diagnosed within 6 Months of Enrollment

Aaron T. Gerds, MD MS, Ivy Altomare, MD, Philomena Colucci, DO, MS, Dilan Paranagama, PhD, John M Burke, MD

Blood (2019) 134 (Supplement_1): 5370.

https://doi.org/10.1182/blood-2019-121386

Published: 2019

Journal Articles

Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms

Maria Carolina Costa Melo Svidnicki, PhD, Paula De Melo Campos, MD, Moisés Alves Ferreira Filho, PhD, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, MD PhD, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 5395.

https://doi.org/10.1182/blood-2019-128764

Published: 2019

Journal Articles

Expression of CD47 and Calr in Myeloproliferative Neoplasms and Myelodysplastic Syndrome: Potential New Therapeutical Targets

Kristian Boasman, BSc, MSc, Matthew J Simmonds, PhD, Ciro R Rinaldi, MD PhD

Blood (2019) 134 (Supplement_1): 5031.

https://doi.org/10.1182/blood-2019-128422

Published: 2019

Journal Articles

Treatment and Outcomes in Heparin-Induced Thrombocytopenia (HIT) in Patients with Neoplasm: A Single Centre Experience

Chieh Min Lai, MD PhD, Tyler Smith, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC

Blood (2019) 134 (Supplement_1): 4951.

https://doi.org/10.1182/blood-2019-122389

Published: 2019

Journal Articles

Study on the Possibility of Emergency Percutaneous Coronary Intervention (PCI) in Myeloproliferative Neoplasms (MPNs) Patients with Acute Coronary Syndrome (ACS)

Ye Chen, Xiuchuan Qin, Xue Han, Beibei Bai, Yingchun Wang

Blood (2019) 134 (Supplement_1): 5375.

https://doi.org/10.1182/blood-2019-124612

Published: 2019

Journal Articles

A New Valuable Technique in Diagnosis and Treatment Monitoring of Myeloproliferative Neoplasms

Yiqian Hu, Sanyun Wu, Yanan Liu, Mengxiao Zhang, Yingying Wang, Liang Shao, Bei Xiong, Xiaoyan Liu, Yicheng Zhang, Rui Lu, Yalan Yu, Ping Luo, Xuelan Zuo

Blood (2019) 134 (Supplement_1): 5377.

https://doi.org/10.1182/blood-2019-128709

Published: 2019

NARROW

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

Description of a knock-in mouse model of JAK2 V617F MPN emerging from a minority of mutated hematopoietic stem cells

JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera

Aberrant Responsiveness of Erythropoiesis to Iron Deficiency in Polycythemia Vera

Thromboembolic Risk Reduction and High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: Results from a Randomized Controlled Study

Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)

Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms Receiving Cytoreductive Therapy with Hydroxyurea

Population Pharmacokinetics of Ruxolitinib in Patients with aGVHD Who Had an Inadequate Response to Corticosteroids

Venetoclax and Cytarabine in AML Transformed from Myelofibrosis

Beyond the Routine CBC: Research CBC Parameters Associated with Myelodysplastic Syndromes and Underlying Mutations

Seven Cases of JAK2 Mutation Negative Chronic Polycythemia Patients with Elevated IGF-1R

Echocardiographic Probability of Pulmonary Hypertension in Myeloproliferative Neoplasms Patients in Chiang-Mai University

Increased Thromboxane in Patients with Polycythemia Vera and Thrombosis: Evidence for Aspirin-Unsuppressible Platelet Activation In Vivo

The Frequency of Calr and MPL Gene Mutations in Jak2 V617F - Positive Chronic Myeloproliferative Neoplasms in Russia

REVEAL: Characteristics of Patients with Polycythemia Vera Who Were Diagnosed within 6 Months of Enrollment

Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms

Expression of CD47 and Calr in Myeloproliferative Neoplasms and Myelodysplastic Syndrome: Potential New Therapeutical Targets

Treatment and Outcomes in Heparin-Induced Thrombocytopenia (HIT) in Patients with Neoplasm: A Single Centre Experience

Study on the Possibility of Emergency Percutaneous Coronary Intervention (PCI) in Myeloproliferative Neoplasms (MPNs) Patients with Acute Coronary Syndrome (ACS)

A New Valuable Technique in Diagnosis and Treatment Monitoring of Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only